Concomitant mitral regurgitation is associated with worse outcomes after T-TEER: insights from the EuroTR registry

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Dominik Felbel

University Hospital of Ulm, Ulm (Germany)

7 More presentations in this session

Presentation thumbnail

Discussant - Treatment and outcome of mitral valve regurgitation

Presentation thumbnail

Echocardiographic insights: factors influencing mitral regurgitation in fabry disease

Doctor A. Vecerova (Prague, CZ)

Presentation thumbnail

Key predictors of non-interventional mitral regurgitation improvement: Insights from the SHEBAHEART registry

Doctor S. Elimeleh (Ramat Gan, IL)

Presentation thumbnail

The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation

Doctor C. Riebel (Cluj Napoca, RO)

Presentation thumbnail

Granger causality analysis of factors driving atrial functional mitral regurgitation in atrial fibrillation

Doctor T. Avram (Cluj Napoca, RO)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Treatment and outcome of mitral valve regurgitation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation

Congress Presentation

Tricuspid regurgitation in the context of severe concomitant left-sided valvular heart disease: patients characteristics and long-term clinical and interventional outcomes

Congress Presentation

Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources